ホーム 米国株 ヘルスケア CRL Charles River Laboratories トップ 業種一覧 リターンランキング ヒートマップ 指数の採用・除外 候補 上場廃止銘柄 米国ETF一覧 ファクターバックテスト ヘルスケア ‹ A Agilent Technologies AARD Aardvark Therapeutics, Inc. ABBV AbbVie ABEO Abeona Therapeutics Inc. ABSI Absci Corporation ABT Abbott Laboratories ABUS Arbutus Biopharma Corporation ACAD ACADIA Pharmaceuticals Inc. ACH Accendra Health, Inc. ACLX Arcellx, Inc. ACRS Aclaris Therapeutics, Inc. ADCT ADC Therapeutics SA ADMA ADMA Biologics Inc ADPT Adaptive Biotechnologies Corporation ADUS Addus HomeCare Corporation AGIO Agios Pharmaceuticals, Inc. AGL agilon health, inc. AHCO AdaptHealth Corp. AIRS AirSculpt Technologies, Inc. AKBA Akebia Therapeutics, Inc. ALEC Alector, Inc. ALGN Align Technology ALHC Alignment Healthcare, Inc. ALKS Alkermes plc ALLO Allogene Therapeutics, Inc. ALMS Alumis Inc. ALT Altimmune, Inc. AMGN Amgen AMLX Amylyx Pharmaceuticals, Inc. AMN AMN Healthcare Services Inc AMPH Amphastar Pharmaceuticals, Inc. AMRX Amneal Pharmaceuticals, Inc. ANAB AnaptysBio, Inc. ANGO AngioDynamics, Inc. ANIK Anika Therapeutics Inc. ANIP ANI Pharmaceuticals, Inc. ANNX Annexon, Inc. AORT Artivion, Inc. APGE Apogee Therapeutics, Inc. AQST Aquestive Therapeutics, Inc. ARAY Accuray Incorporated ARCT Arcturus Therapeutics Holdings ARDT Ardent Health, Inc. ARDX Ardelyx, Inc. ARQT Arcutis Biotherapeutics, Inc. ARVN Arvinas, Inc. ARWR Arrowhead Pharmaceuticals, Inc. ASTH Astrana Health Inc. ATEC Alphatec Holdings, Inc. ATRC AtriCure, Inc. ATYR aTyr Pharma, Inc. AUPH Aurinia Pharmaceuticals Inc AURA Aura Biosciences, Inc. AVAH Aveanna Healthcare Holdings Inc AVBP ArriVent BioPharma, Inc. AVIR Atea Pharmaceuticals, Inc. AVNS Avanos Medical, Inc. AVR Anteris Technologies Global Cor AVXL Anavex Life Sciences Corp. AXGN AxoGen, Inc. AXSM Axsome Therapeutics, Inc. AZTA Azenta, Inc. BAX Baxter International BBIO BridgeBio Pharma, Inc. BBNX Beta Bionics, Inc. BCAX Bicara Therapeutics Inc. BCRX BioCryst Pharmaceuticals, Inc. BDX Becton Dickinson BEAM Beam Therapeutics Inc. BFLY Butterfly Network, Inc. BHVN Biohaven Ltd. BIIB Biogen BIOA BioAge Labs, Inc. BKD Brookdale Senior Living Inc. BLFS BioLife Solutions, Inc. BMY Bristol Myers Squibb BNTC Benitec Biopharma Inc. BSX Boston Scientific BTMD Biote Corp. BTSG BrightSpring Health Services, I BVS Bioventus Inc. CADL Candel Therapeutics, Inc. CAH Cardinal Health CAPR Capricor Therapeutics, Inc. CARL Carlsmed, Inc. CATX Perspective Therapeutics, Inc. CBLL CeriBell, Inc. CCRN Cross Country Healthcare, Inc. CDNA CareDx, Inc. CDXS Codexis, Inc. CELC Celcuity Inc. CERS Cerus Corporation CGEM Cullinan Therapeutics, Inc. CGON CG Oncology, Inc. CHRS Coherus Oncology, Inc. CI Cigna CLDX Celldex Therapeutics, Inc. CLOV Clover Health Investments, Corp. CLPT ClearPoint Neuro Inc. CMPX Compass Therapeutics, Inc. CNC Centene Corporation CNMD CONMED Corporation COGT Cogent Biosciences, Inc. COLL Collegium Pharmaceutical, Inc. CON Concentra Group Holdings Parent COO Cooper Companies (The) COR Cencora CPRX Catalyst Pharmaceuticals, Inc. CRDF Cardiff Oncology, Inc. CRL Charles River Laboratories CRMD CorMedix Inc. CRNX Crinetics Pharmaceuticals, Inc. CRSP CRISPR Therapeutics AG CRVS Corvus Pharmaceuticals, Inc. CSTL Castle Biosciences, Inc. CTEV Claritev Corporation CTKB Cytek Biosciences, Inc. CV CapsoVision, Inc. CVRX CVRx, Inc. CVS CVS Health CYH Community Health Systems, Inc. CYTK Cytokinetics, Incorporated DAWN Day One Biopharmaceuticals, Inc. DCGO DocGo Inc. DCTH Delcath Systems, Inc. DERM Journey Medical Corporation DFTX Definium Therapeutics, Inc. DGX Quest Diagnostics DH Definitive Healthcare Corp. DHR Danaher Corporation DMAC DiaMedica Therapeutics Inc. DNA Ginkgo Bioworks Holdings, Inc. DNLI Denali Therapeutics Inc. DNTH Dianthus Therapeutics, Inc. DRUG Bright Minds Biosciences Inc. DSGN Design Therapeutics, Inc. DVA DaVita DXCM Dexcom DYN Dyne Therapeutics, Inc. EBS Emergent BioSolutions Inc. EDIT Editas Medicine, Inc. EHAB Enhabit, Inc. ELDN Eledon Pharmaceuticals, Inc. ELMD Electromed, Inc. ELV Elevance Health ELVN Enliven Therapeutics, Inc. EMBC Embecta Corp. ENOV Enovis Corporation ENSG The Ensign Group, Inc. ENTA Enanta Pharmaceuticals, Inc. EOLS Evolus, Inc. Common Stock ERAS Erasca, Inc. ESPR Esperion Therapeutics, Inc. ETON Eton Pharmaceuticals, Inc. EVH Evolent Health, Inc EW Edwards Lifesciences EWTX Edgewise Therapeutics, Inc. EYPT EyePoint Pharmaceuticals, Inc. FATE Fate Therapeutics, Inc. FDMT 4D Molecular Therapeutics, Inc. FENC Fennec Pharmaceuticals Inc. FHTX Foghorn Therapeutics Inc. FLGT Fulgent Genetics, Inc. FOLD Amicus Therapeutics, Inc. FTRE Fortrea Holdings Inc. FULC Fulcrum Therapeutics, Inc. GEHC GE HealthCare GERN Geron Corporation GH Guardant Health, Inc. GILD Gilead Sciences GKOS Glaukos Corporation GLSI Greenwich LifeSciences, Inc. GLUE Monte Rosa Therapeutics, Inc. GOSS Gossamer Bio, Inc. GRAL GRAIL, Inc. GRDN Guardian Pharmacy Services, Inc. GYRE Gyre Therapeutics, Inc. HAE Haemonetics Corporation HCA HCA Healthcare HCAT Health Catalyst, Inc HCSG Healthcare Services Group, Inc. HIMS Hims & Hers Health, Inc. HOLX Hologic HQY HealthEquity, Inc. HRMY Harmony Biosciences Holdings, Inc. HROW Harrow, Inc. HRTX Heron Therapeutics, Inc. HSIC Henry Schein HSTM HealthStream, Inc. HTFL Heartflow, Inc. HUM Humana HUMA Humacyte, Inc. IART Integra LifeSciences Holdings Corporation IBRX ImmunityBio, Inc. ICUI ICU Medical, Inc. IDXX Idexx Laboratories IDYA IDEAYA Biosciences, Inc. IKT Inhibikase Therapeutics, Inc. IMNM Immunome, Inc. IMVT Immunovant, Inc. INBX Inhibrx Biosciences, Inc. INCY Incyte INDV Indivior Pharmaceuticals, Inc. INGN Inogen, Inc INMB INmune Bio Inc. INNV InnovAge Holding Corp. INVA Innoviva, Inc. IOVA Iovance Biotherapeutics, Inc. IQV IQVIA IRMD iRadimed Corporation IRON Disc Medicine, Inc. IRTC iRhythm Holdings, Inc. IRWD Ironwood Pharmaceuticals, Inc. ISRG Intuitive Surgical ITGR Integer Holdings Corporation JANX Janux Therapeutics, Inc. JBIO Jade Biosciences, Inc. JNJ Johnson & Johnson JYNT The Joint Corp. KALV KalVista Pharmaceuticals, Inc. KIDS OrthoPediatrics Corp. KMTS Kestra Medical Technologies, Ltd. KOD Kodiak Sciences Inc. KRMD KORU Medical Systems, Inc. KROS Keros Therapeutics, Inc. KRRO Korro Bio, Inc. KRYS Krystal Biotech, Inc. KURA Kura Oncology, Inc. KYMR Kymera Therapeutics, Inc. LAB Standard BioTools Inc. LBRX LB Pharmaceuticals Inc LENZ LENZ Therapeutics, Inc. LFCR Lifecore Biomedical, Inc. LFMD LifeMD, Inc. LFST LifeStance Health Group, Inc. LGND Ligand Pharmaceuticals Incorporated LH Labcorp LIVN LivaNova PLC LLY Lilly (Eli) LMAT LeMaitre Vascular, Inc. LNSR LENSAR, Inc. LNTH Lantheus Holdings, Inc. LQDA Liquidia Corporation LRMR Larimar Therapeutics, Inc. LUCD Lucid Diagnostics Inc. LUNG Pulmonx Corporation LXEO Lexeo Therapeutics, Inc. MASS 908 Devices Inc. MAZE Maze Therapeutics, Inc. MBX MBX Biosciences, Inc. MCK McKesson Corporation MD Pediatrix Medical Group, Inc. MDGL Madrigal Pharmaceuticals, Inc. MDT Medtronic MDWD MediWound Ltd. MDXG MiMedx Group, Inc MGTX MeiraGTx Holdings plc MIRM Mirum Pharmaceuticals, Inc. MLYS Mineralys Therapeutics, Inc. MMSI Merit Medical Systems, Inc. MNKD MannKind Corporation MNPR Monopar Therapeutics Inc. MOH Molina Healthcare MPLT MapLight Therapeutics, Inc. MRK Merck & Co. MRNA Moderna MRVI Maravai LifeSciences Holdings, Inc. MTD Mettler Toledo MXCT MaxCyte, Inc. MYGN Myriad Genetics, Inc. MYO Myomo Inc. NAGE Niagen Bioscience, Inc. NEO NeoGenomics, Inc. NEOG Neogen Corporation NGNE Neurogene Inc. NHC National HealthCare Corporation NKTX Nkarta, Inc. NNOX NANO-X IMAGING LTD NPCE Neuropace, Inc. NRC National Research Corporation NRIX Nurix Therapeutics, Inc. NTLA Intellia Therapeutics, Inc. NUTX Nutex Health Inc. NUVB Nuvation Bio Inc. NUVL Nuvalent, Inc. NVAX Novavax, Inc. NVCR NovoCure Limited NVCT Nuvectis Pharma, Inc. OABI OmniAb, Inc. OCUL Ocular Therapeutix, Inc. OFIX Orthofix Medical Inc. OLMA Olema Pharmaceuticals, Inc. OM Outset Medical, Inc. OMCL Omnicell, Inc. OMDA Omada Health, Inc. OMER Omeros Corporation OPCH Option Care Health, Inc. OPK Opko Health, Inc. OPRX OptimizeRx Corporation ORGO Organogenesis Holdings Inc. ORIC Oric Pharmaceuticals, Inc. ORKA Oruka Therapeutics, Inc. OSCR Oscar Health, Inc. OSUR OraSure Technologies, Inc. PACB Pacific Biosciences of Californ PACS PACS Group, Inc. PAHC Phibro Animal Health Corporatio PBH Prestige Consumer Healthcare In PBYI Puma Biotechnology Inc PCRX Pacira BioSciences, Inc. PCVX Vaxcyte, Inc. PDEX Pro-Dex, Inc. PFE Pfizer PGEN Precigen, Inc. PGNY Progyny, Inc. PHAT Phathom Pharmaceuticals, Inc. PHR Phreesia, Inc. PLSE Pulse Biosciences, Inc PLX Protalix BioTherapeutics, Inc. PNTG The Pennant Group, Inc. PODD Insulet Corporation PRAX Praxis Precision Medicines, Inc. PRCT PROCEPT BioRobotics Corporation PRME Prime Medicine, Inc. PRTA Prothena Corporation plc PRVA Privia Health Group, Inc. PSNL Personalis, Inc. PTCT PTC Therapeutics, Inc. PTGX Protagonist Therapeutics, Inc. PVLA Palvella Therapeutics, Inc. QDEL QuidelOrtho Corporation QSI Quantum-Si Incorporated QTRX Quanterix Corporation RAPP Rapport Therapeutics, Inc. RCEL Avita Medical, Inc. RCKT Rocket Pharmaceuticals, Inc. RCUS Arcus Biosciences, Inc. RDNT RadNet, Inc. REGN Regeneron Pharmaceuticals, Inc. REPL Replimune Group, Inc. RGNX REGENXBIO Inc. RIGL Rigel Pharmaceuticals, Inc. RLAY Relay Therapeutics, Inc. RMD ResMed Inc. RNA Atrium Therapeutics, Inc. RNAC Cartesian Therapeutics, Inc. RVTY Revvity, Inc. RXRX Recursion Pharmaceuticals, Inc. RXST RxSight, Inc. RYTM Rhythm Pharmaceuticals, Inc. RZLT Rezolute, Inc. SANA Sana Biotechnology, Inc. SDGR Schrodinger, Inc. SEM Select Medical Holdings Corpora SEPN Septerna, Inc. SGHT Sight Sciences, Inc. SGRY Surgery Partners, Inc. SI Shoulder Innovations, Inc. SIBN SI-BONE, Inc. SIGA SIGA Technologies Inc. SION Sionna Therapeutics, Inc. SLDB Solid Biosciences Inc. SLNO Soleno Therapeutics, Inc. SLP Simulations Plus, Inc. SLS SELLAS Life Sciences Group, Inc SMTI Sanara MedTech Inc. SNDA Sonida Senior Living, Inc. SNDX Syndax Pharmaceuticals, Inc. SNWV SANUWAVE Health, Inc. SOLV Solventum SPOK Spok Holdings, Inc. SPRY ARS Pharmaceuticals, Inc. SRRK Scholar Rock Holding Corporation SRTA Strata Critical Medical, Inc. STAA STAAR Surgical Company STE Steris STIM Neuronetics, Inc. STOK Stoke Therapeutics, Inc. STXS Stereotaxis, Inc. SUPN Supernus Pharmaceuticals, Inc. SVRA Savara, Inc. SYK Stryker Corporation SYRE Spyre Therapeutics, Inc. TALK Talkspace, Inc. TARA Protara Therapeutics, Inc. TARS Tarsus Pharmaceuticals, Inc. TBPH Theravance Biopharma, Inc. TBRG TruBridge, Inc. TCMD Tactile Systems Technology, Inc TDOC Teladoc Health, Inc. TECH Bio-Techne TECX Tectonic Therapeutic, Inc. TERN Terns Pharmaceuticals, Inc. TGTX TG Therapeutics, Inc. TKNO Alpha Teknova, Inc. TLSI TriSalus Life Sciences, Inc. TMCI Treace Medical Concepts, Inc. TMDX TransMedics Group, Inc. TMO Thermo Fisher Scientific TNDM Tandem Diabetes Care, Inc. TNGX Tango Therapeutics, Inc. TNXP Tonix Pharmaceuticals Holding Corp. TOI The Oncology Institute, Inc. TRDA Entrada Therapeutics, Inc. TRVI Trevi Therapeutics, Inc. TSHA Taysha Gene Therapies, Inc. TVGN Tevogen Bio Holdings Inc. TVRD Tvardi Therapeutics, Inc. TVTX Travere Therapeutics, Inc. TWST Twist Bioscience Corporation TXG 10x Genomics, Inc. TYRA Tyra Biosciences, Inc. UFPT UFP Technologies, Inc. UHS Universal Health Services UNH UnitedHealth Group UPB Upstream Bio, Inc. URGN UroGen Pharma Ltd. USPH U.S. Physical Therapy, Inc. UTMD Utah Medical Products, Inc. VCEL Vericel Corporation VCYT Veracyte, Inc. VERA Vera Therapeutics, Inc. VIR Vir Biotechnology, Inc. VMD Viemed Healthcare, Inc. VNDA Vanda Pharmaceuticals Inc. VRDN Viridian Therapeutics, Inc. VREX Varex Imaging Corporation VRTX Vertex Pharmaceuticals VSTM Verastem, Inc. VTRS Viatris VYGR Voyager Therapeutics, Inc. WAT Waters Corporation WAY Waystar Holding Corp. WEAV Weave Communications, Inc. WGS GeneDx Holdings Corp. WRBY Warby Parker Inc. WST West Pharmaceutical Services WVE Wave Life Sciences Ltd. XENE Xenon Pharmaceuticals Inc. XERS Xeris Biopharma Holdings, Inc. XNCR Xencor, Inc. XOMA XOMA Royalty Corporation ZBH Zimmer Biomet ZBIO Zenas BioPharma, Inc. ZTS Zoetis ZVRA Zevra Therapeutics, Inc. ZYME Zymeworks Inc. › セクターの一覧 110 / 447
CRL Charles River Laboratories の財務データ・業績推移
CRL（Charles River Laboratories）が米国証券取引委員会（SEC）へ提出した年次報告書（annual report / Form 10-K）のXBRLを、そのまま年度別に並べた財務データです。掲載範囲はFY2009〜FY2025の17期。金額は原則として提出時の米ドル表示、利益は株式報酬（SBC）を費用控除したGAAPベースです。
直近のFY2025（決算期2025-12-27）は売上高$4.02B、営業利益$25.2M、純利益-$144.3M、希薄化後EPS$-2.91。
CRLの年次サマリー（SEC提出書類）
損益計算書
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
売上高
$1.68B $1.86B $2.27B $2.62B $2.92B $3.54B $3.98B $4.13B $4.05B $4.02B 売上総利益
$179.9M $167.7M $226.4M $262.3M $300.0M — — — — — 営業利益
$237.4M $287.5M $331.4M $351.2M $432.7M $589.9M $651.0M $617.3M $227.3M $25.2M 税引前利益
$222.9M $297.0M $281.7M $304.1M $447.1M $480.7M $623.0M $581.3M $93.1M -$99.5M 純利益（GAAP）
$154.8M $123.4M $226.4M $252.0M $364.3M $391.0M $486.2M $474.6M $10.3M -$144.3M EBITDA
$364.1M $418.7M $493.2M $549.2M $667.7M $855.4M $954.8M $931.4M $589.1M $428.5M 純利益率
9.2% 6.6% 10.0% 9.6% 12.5% 11.0% 12.2% 11.5% 0.3% -3.6%
貸借対照表
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
総資産
$2.71B $2.93B $3.86B $4.69B $5.49B $7.02B $7.60B $8.20B $7.53B $7.14B 流動資産
$656.8M $826.6M $897.8M $1.02B $1.20B $1.27B $1.44B $1.61B $1.40B $1.45B 現金及び現金同等物
$117.6M $163.8M $195.4M $238.0M $228.4M $241.2M $233.9M $276.8M $194.6M $213.8M 負債合計
$1.86B $1.87B $2.52B $3.03B $3.35B $4.43B $4.58B $4.54B $4.02B $3.92B 長期借入金
$1.19B $1.09B $1.63B — — — — — — — 株主資本
$836.8M $1.05B $1.32B $1.63B $2.11B $2.53B $2.98B $3.60B $3.46B $3.16B
キャッシュフロー計算書
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
営業キャッシュフロー
— — $441.1M — — $760.8M $619.6M $683.9M $734.6M $737.6M 設備投資
$55.3M $82.4M $140.1M $140.5M $166.6M $228.8M $324.7M $318.5M $233.0M $219.2M フリーキャッシュフロー
— — $301.1M — — $532.0M $294.9M $365.4M $501.6M $518.5M 自己株式取得
$12.3M $106.9M $13.8M $18.1M $24.0M $40.7M $38.7M $24.2M $119.2M $360.7M
1株当たり・株式数
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
EPS（基本・GAAP）
$3.29 $2.60 $4.72 $5.17 $7.35 $7.77 $9.57 $9.27 $0.20 $-2.91 EPS（希薄化後・GAAP）
$3.23 $2.54 $4.62 $5.07 $7.20 $7.60 $9.48 $9.22 $0.20 $-2.91 1株当たり純資産
$17.67 $22.05 $27.33 $33.40 $42.49 $50.21 $58.42 $70.06 $67.69 $64.30 希薄化後平均株式数
47.96M 48.56M 49.02M 49.69M 50.61M 51.43M 51.30M 51.45M 51.63M 49.56M
出典: SEC提出書類（10-K / annual report）。値はXBRLの報告値をそのまま用い、四半期への按分や推測は行っていません。1株当たり指標と株式数は、その後の株式分割をさかのぼって反映し、いまの株価と同じ株数の基準にそろえています（分割前の年度は提出書類の数字と異なります。報告値はAPIの reported に残しています）。
売上高と営業利益の推移で、事業規模と利益率の変化を確認できます。
EPS・キャッシュフロー・株主資本を組み合わせると、会計上の利益と現金創出力の差を見やすくなります。
同じ銘柄の株価チャート 、ヘルスケアの米国株 もあわせて確認できます。